Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers

Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Michael A. Pulsipher(Primary Children's Hospital), James Gajewski(The University of Texas MD Anderson Cancer Center), Deidre M. Kiefer(National Marrow Donor Program), Navneet S. Majhail(Sarah Cannon), Galen E. Switzer(University of Pittsburgh), Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Raquel M. Schears(Mayo Clinic in Arizona), Peiman Hematti(UW Health University Hospital), Kimberley A. Kasow(University of North Carolina at Chapel Hill), Hillard M. Lazarus(University Hospitals of Cleveland), Paul V. O’Donnell(Johns Hopkins Hospital), Muneer H. Abidi(Spectrum Health), Tanya L. Pedersen, Andrew Artz, Christopher E. Dandoy(Cincinnati Children's Hospital Medical Center), Baldeep Wirk(Boston University), Hisham Abdel‐Azim(University of Southern California), David F. Stroncek(Yale University), Richard F. Olsson(AstraZeneca (Netherlands)), Jane L. Liesveld(Strong Memorial Hospital), Pintip Chitphakdithai(National Marrow Donor Program), Görgün Akpek(Banner MD Anderson Cancer Center), Bipin N. Savani(Vanderbilt University Medical Center), Miguel Ángel Díaz(Hospital Infantil Universitario Niño Jesús), Rammurti T. Kamble(Baylor College of Medicine), Dennis L. Confer(National Marrow Donor Program), Eric Williams, John R. Wingard(University of Florida Health)
Transplantation and Cellular Therapy
June 23, 2015
Cited by 13


Related Papers